Other clinically relevant lipoprotein biomarkers (apolipoprotein A and B), and proinflammatory adipokines [5] may be examined for a more comprehensive understanding of CHM effects on lipid metabolism and cardiovascular risk among participants with obesity. The gene discussed is PPIB; the disease is obesity due to melanocortin 4 receptor deficiency.